The results cannot be extrapolated to humans, researchers caution.

A small pilot study suggests the approach can identify effective treatments already approved for other cancers.

The increased risk is slight, but aligns with a longstanding hypothesis that having more cells in one’s body leads to more chances for those cells to become cancerous.

Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.

Combining data from the genetic testing techniques can guide patient care, scientists say.

This year’s winners also include the developers of nusinersen, an oligonucleotide therapeutic for spinal muscular atrophy.

The immunologists, honored with the 2018 award in Physiology or Medicine, pioneered immunotherapy, which harnesses the body’s immune system to fight cancer.

Money from the NIH’s budget, among others, will be used to care for kids in federal custody.

The awards for comical but practical scientific discovery also include cannibalism and self-colonoscopy.